Crabtree JS - Search Results

1

DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.

Yao J, Bergsland E, Aggarwal R, Aparicio A, Beltran H, Crabtree JS, Hann CL, Ibrahim T, Byers LA, Sasano H, Umejiego J, Pavel M. Yao J, et al. Among authors: crabtree js. Oncologist. 2022 Nov 3;27(11):940-951. doi: 10.1093/oncolo/oyac161. Oncologist. 2022. PMID: 35983951 Free PMC article. Review.

2

Notch Signaling in Neuroendocrine Tumors.

Crabtree JS, Singleton CS, Miele L. Crabtree JS, et al. Front Oncol. 2016 Apr 14;6:94. doi: 10.3389/fonc.2016.00094. eCollection 2016. Front Oncol. 2016. PMID: 27148486 Free PMC article. Review.

3

Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.

Crabtree JS. Crabtree JS. Front Endocrinol (Lausanne). 2017 Dec 4;8:341. doi: 10.3389/fendo.2017.00341. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 29255447 Free PMC article. Review.

4

Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors.

Crabtree JS. Crabtree JS. Front Oncol. 2022 Jun 7;12:901435. doi: 10.3389/fonc.2022.901435. eCollection 2022. Front Oncol. 2022. PMID: 35747820 Free PMC article. Review.

5

Retinoblastoma-binding protein 2 (RBP2) is frequently expressed in neuroendocrine tumors and promotes the neoplastic phenotype.

Maggi EC, Trillo-Tinoco J, Struckhoff AP, Vijayaraghavan J, Del Valle L, Crabtree JS. Maggi EC, et al. Among authors: crabtree js. Oncogenesis. 2016 Aug 22;5(8):e257. doi: 10.1038/oncsis.2016.58. Oncogenesis. 2016. PMID: 27548814 Free PMC article.

6

Breast Cancer Stem Cells.

Crabtree JS, Miele L. Crabtree JS, et al. Biomedicines. 2018 Jul 17;6(3):77. doi: 10.3390/biomedicines6030077. Biomedicines. 2018. PMID: 30018256 Free PMC article. Review.

7

Targeting Notch in oncology: the path forward.

Majumder S, Crabtree JS, Golde TE, Minter LM, Osborne BA, Miele L. Majumder S, et al. Among authors: crabtree js. Nat Rev Drug Discov. 2021 Feb;20(2):125-144. doi: 10.1038/s41573-020-00091-3. Epub 2020 Dec 8. Nat Rev Drug Discov. 2021. PMID: 33293690 Review.

8

ISGylation is increased in the peripheral blood mononuclear cells derived from symptomatic COVID-19 patients.

Schwartzenburg J, Reed R, Koul H, Zea AH, Shellito J, Miele L, Crabtree JS, Desai S. Schwartzenburg J, et al. Among authors: crabtree js. Exp Biol Med (Maywood). 2022 May;247(10):842-847. doi: 10.1177/15353702221075606. Epub 2022 Feb 7. Exp Biol Med (Maywood). 2022. PMID: 35130743 Free PMC article.

9

Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion.

Loupe JM, Miller PJ, Bonner BP, Maggi EC, Vijayaraghavan J, Crabtree JS, Taylor CM, Zabaleta J, Hollenbach AD. Loupe JM, et al. Among authors: crabtree js. Oncogenesis. 2016 Jul 25;5(7):e246. doi: 10.1038/oncsis.2016.53. Oncogenesis. 2016. PMID: 27454080 Free PMC article.

10

miR-24 regulates menin in the endocrine pancreas.

Vijayaraghavan J, Maggi EC, Crabtree JS. Vijayaraghavan J, et al. Among authors: crabtree js. Am J Physiol Endocrinol Metab. 2014 Jul 1;307(1):E84-92. doi: 10.1152/ajpendo.00542.2013. Epub 2014 May 13. Am J Physiol Endocrinol Metab. 2014. PMID: 24824656 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page